Back to Nuveen Asset Management, LLC Nuveen Asset Management, LLC

CERECERE
14 quarters

Position history for Nuveen Asset Management, LLCNuveen Asset Management, LLC's holdings in CEREVEL THERAPEUTICS HLDNG I

Nuveen Asset Management, LLC previously held 0 shares of CERE (CEREVEL THERAPEUTICS HLDNG I), worth $0 as of 2024-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$3.8M

Total Shares Change

-149,651

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%
0
2024-Q2
Decreased
138,380
-33.5%
$5.7M0.0%
0
2024-Q1
Decreased
208,095
-1.1%
$8.8M0.0%
0
2023-Q4
Increased
210,481
+41.6%
$8.9M0.0%
37
2023-Q3
Decreased
148,610
-0.7%
$3.2M0.0%
0
2023-Q2
Increased
149,716
+4.8%
$4.8M0.0%
28
2023-Q1
Decreased
142,906
-2.1%
$3.5M0.0%
0
2022-Q4
Decreased
145,968
-2.3%
$4.6M0.0%
0
2022-Q3
Decreased
149,411
-31.7%
$4.2M0.0%
0
2022-Q2
Increased
218,745
+27.9%
$5.8M0.0%
34
2022-Q1
Increased
171,055
+2.0%
$5.3M0.0%
28
2021-Q4
Decreased
167,698
-14.4%
$5.4M0.0%
0
2021-Q3
Increased
195,983
+31.0%
$5.8M0.0%
34
2021-Q2
New
149,651
-
$3.8M0.0%
37

Other major holders of CERE: Avoro Capital Advisors LLC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used